Featured Posts
National Review
Prescription Drugs Save Lives at a (Mostly) Reasonable Cost
Prescription drugs are an extraordinary lifesaving and life-enhancing technology, so integrated into our daily lives that, nowadays, we perhaps take them for granted. Headlines and…
News Release
FDA deserves credit for approval pancreatic cancer drug
The FDA on August 26 approved a new breakthrough drug to treat pancreatic cancer. CEI Senior Fellow and Economist Jeremy Nighohossian praised…
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
Search Posts
Washington Examiner
Government Health Programs Skew Incentives; People Respond
Forget QE2; this is QED. When a health-care providing government pays doctors according to how many procedures they perform, rather than by the effectiveness or…
Washington Examiner
The Food Industry Plays Regulatory Roulette
Washington Examiner
Food safety bill update (and welcome readers)
Washington Examiner
More FDA Authority Won’t Improve Food Safety
In its rush to enact sweeping new food safety legislation during the lame-duck session, Congress hit a procedural roadblock that may put the bill off…
Washington Examiner
The Environmental Impact Subterfuge
Action needs to be taken to prevent anti-biotech activists from co-opting environmental law to derail the planting of transgenic crops that have already received regulatory…
Washington Examiner